Benoit Van Den Eynde

City:

Genval

Country:

Belgium

Published Applications:

Last publication date:

2023-06-01

Top Assignees for applications by Benoit Van Den Eynde

The entities that hold a legal rights for patent applications filed by inventor Van Den Eynde Benoit:

UNIVERSITÉ CATHOLIQUE DE LOUVAIN 2 Louvain-la-Neuve, Belgium
UNIVERSITE CATHOLIQUE DE LOUVAIN 1 Louvain-La-Neuve, Belgium
CLINIQUES UNIVERSITAIRES SAINT-LUC 1 Bruxelles, Belgium
Institut Pasteur, a corporation of France 1 Paris, France
Ludwig Institute for Cancer, a corporation of New York 1 New York, NY United States

Recent patent applications by Van Den Eynde Benoit

Benoit Van Den Eynde from Genval, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-06-01

US20230165836A1

Human necessities

ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER

#2 | 2023-05-18

US20230149360A1

Human necessities

ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS

#3 | 2010-12-09

US20100310594A1

Chemistry; metallurgy

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#4 | 2010-10-28

US20100273671A1

Chemistry; metallurgy

METHOD FOR THE DETERMINATION AND THE CLASSIFICATION OF RHEUMATIC CONDITIONS

#5 | 2005-12-08

US20050271679A1

Chemistry; metallurgy

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

InventorID:

3681100 ⎘